A compensatory increase in IDO activity in models of rheumatoid arthritis was shown, indeed systemic inhibition of tryptophan catabolism correlated early with an increased production of IFN-γ and IL-17 and later with an increased infiltration of Th1 and Th17 cells in the inflamed joints, increasing disease severity [231]. Here, IL17A is linked to rheumatoid arthritis.